← Open Payments lookup

MONICA MOORE: Open Payments

NPI 1871810812 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,379 in 71 payments from 12 companies in 2025. Trend: 2023 $381 · 2024 $1,374 · 2025 $1,379

Food & beverage: $1,379
CompanyPaymentsAmount
ABBVIE INC.40$625
Madrigal Pharmaceuticals8$378
Ardelyx, Inc.4$66
Takeda Pharmaceuticals U.S.A., Inc.3$59
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$49
Aimmune Therapeutics, Inc.3$47
Gilead Sciences, Inc.2$42
Janssen Biotech, Inc.2$34
Novo Nordisk Inc2$33
EVOKE PHARMA, INC.1$17

Products named: REZDIFFRA, LINZESS, RINVOQ, SKYRIZI, CREON, IBSRELA, ENTYVIO, TREMFYA.

Industry payments across AL — which companies pay providers there.